Brownsville Moves to Level 2 On Threat Level Matrix

Translate to Spanish or other 102 languages!

Effective 7/5/22, the City of Brownsville has increased the threat level matrix to level two due to a rising number of COVID-19 cases. Image for illustration purposes
Effective 7/5/22, the City of Brownsville has increased the threat level matrix to level two due to a rising number of COVID-19 cases. Image for illustration purposes

Mega Doctor News

- Advertisement -

BROWNSVILLE, Texas – Effective 7/5/22, the City of Brownsville has increased the threat level matrix to level two due to a rising number of COVID-19 cases. During the past two weeks, virus transmission rates have increased, especially for unvaccinated individuals.

The number of positive COVID-19 cases has surpassed 1,000 cases, with two confirmed deaths this week. The public must stay vigilant and aware that this can take a toll on every member of the community, including the most vulnerable and healthcare staff. 

“We want to remind citizens that it is essential to continue to be vigilant and practice safe health practices. Please remember to wash your hands, use hand sanitizer, practice social distancing, and wear a mask,” said Dr. Rodriguez.

- Advertisement -

Currently, the vaccination rate for Cameron County is at 92.80% for individuals 65 years and older and 81.83% for people five years and older.  Getting the COVID-19 vaccine has been found to be the safest and most effective way to protect the immune system from COVID-19. Call the COVID-19 Hotline at 956-394-0012 or visit the Brownsville Cares website for more information regarding COVID-19 vaccines.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -